| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Why Thinking Is Too Important To Be Left Only To Management |
|
Digg It - Why Thinking Is Too Important To Be Left Only To Management
In creating "flow manufacturing" or just in time manufacturing the idea at Toyota According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product was to make sure the flow was hardly ever broken or interrupted. After all the i ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in dea was to maximize on production and the way to do this was to keep an assembly lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. line moving. For this reason a worker's main responsibility appears to be to wor here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe k and not to think when they are supposed to be keeping production moving. Howev d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro er a worker on the plant floor has another much more significant role to play oth ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc er than just “do the work”. They are also expected to be problem solvers and perf easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ormance improvers. What this means is that when there is a problem on the assemb nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ly line, rather than just keep on working for the sake of keeping the assembly li and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ne moving, a worker has the power to stop the line. They are then supposed to thi ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi nk of a solution, implement it and then get the line moving again. This greatly l ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a imits waste from units being rejected by quality control later and eliminates the dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod need to keep extra material on site to use for the manufacturing of replacement cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin products. This is usually to replace those units that did not pass quality contro tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen l or were obviously seen to be defective long before they even arrived at quality t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel control. In other words, in lean manufacturing or flow manufacturing the issue ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust of leaving all the thinking to management does not arise. Thinking is in fact con y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products sidered to be too important a task to be left only to a handful of managers. The . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de results of this kind of thinking speak for itself. It’s applicable in all situat elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ions, not just manufacturing. Copyright © 2006 Chuck Yorke - All Rights Reserved tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Personal Branding - The Foundation Of Massive Success Tips For Answering Interview Questions
|